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Methods: A model of HBV is described by: x, y, v, z
which represent uninfected cells, infected cells, free virus,
and CTL cells respectively. Here the infected cells were
divided into two parts with one part having drug resistance
and the other part having none. The model includes
11 parameters: l, d, b, a, p, k1, k2, u, c, b, t. During
treatment of AD, we chose {l, d, b, a, p, k1, k2, u, c, b,
t} = {4.621e5, 6.9e-3, 7.08e-11, 6.9e-3, 1.5e-9, 1, 0.93,
0.08, 0.35, 2.251e-2, 10.6}. During treatment of ETV, we
choose {k2, u, t} = {0.99, 0.18, 1.6{ with other parameters
unchanged. Here the change of the three parameters can
imply the difference of therapy effect of AD and ETV.
Results: The simulation data of our model are qualitatively
agreement with the clinical ones, especially the HBV DNA
decrease when switch to ETV treatment.
Conclusion: The results show that our time-delay therapy
model may possibly capture the dynamics of HBV infection
and anti-HBV infection treatment under different drug.
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Background: The prevalence and infection hepatitis B virus
is a serious problem in the world. Recent studies showed
that the PD-1/PD-L pathway contributed directly to T cell
dysfunction and lack of viral control in established chronic
infection. In the present study, we try to improve the
immune effect of HBsAg vaccination in HBV transgenic mice
by blocking PD-1/PD-L pathway in vivo and to seek new
methods for the treatment of chronic hepatitis B.
Methods: Fifteen HBV Tg mice were randomized into
three groups with 5 mice each, and designated as HBsAg
vaccine group, vaccine and B7-H1 group and control
group, respectively. The anti-HBs of the three groups were
detected by ELISA. The splenocytes of the mice were
stimulated with HBsAg (10mg/ml). The concentrations of
IL-2 and IFN-g were detected by ELISA. The number of IFN-g
secreting cells was measured by ELISPOT.
Results: The anti-B7-H1 in serum was detected in the mice
immunized with B7-H1 and the antibody titer increased
with the immune times. There was no difference of anti-
HBs positive rate between HBsAg group and HBsAg+B7-
H1 group at 6th week and 8th week after immunization.
Concentrations of IL-2 and IFN-g were elevated in both
HBsAg group and HBsAg+B7-H1 group than that in control
group (P < 0.05). Moreover, The numbers of HBs-specifc IFN-g
secreting T cells is also increased in both the HBsAg group
and HBsAg+B7-H1 group when compared with the control
group, and the outcomes showed no difference between
the two experimental groups (P > 0.05).
Conclusion: (1) HBsAg vaccine can increase the cellular and
humoral immune response in HBV Tg mice and reconstruct
immune response to HBsAg. (2) B7-H1 vaccine can not
enhance the humoral and cell immune responses in HBV
Tg mice immunized with HBsAg.
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Objective: The aim of this study was to analyze variables
that may affect survival of patients with HBV-related
liver failure, identify the independent predictors for
development of a prognostic survival model, and evaluate
its predictive power.
Methods: In this retrospective cohort study, 569 patients
were diagnosed with HBV-related liver failure between
January 2004 and December 2007. Univariate and
multivariate Cox proportional hazards regression analyses
were applied to such variables as age, sex, disease
complications, biochemical markers, coagulation markers,
and HBV DNA loads to identify independent risk factors
for establishment of a prognostic survival model, and 79
conﬁrmed cases of HBV-related liver failure were used to
evaluate the model’s predictive capacity.
Results: Hepatic encephalopathy, pulmonary infection,
upper gastrointestinal bleeding (UGIB), albumin, AST, creati-
nine, international normalized ratio (INR) were determined
to be independent risk factors (P< 0.01); accordingly, the
prognostic index (PI) = 4.98× hepatic encephalopathy +
4.57×pulmonary infection + 4.41× upper gastrointestinal
bleeding 9.69× Ln(Alb[g/L]) + 2.46× Ln(AST[U/L]) +
5.18× Ln(Cr[mmol/L]) + 3.35×Ln(INR) 15.36, which was
able to accurately predict the 90-d survival.
Conclusions: Survival of patients with HBV-related
liver failure can be accurately predicted based on
seven independent predictors: hepatic encephalopathy,
pulmonary infection, upper gastrointestinal bleeding
(UGIB), albumin, AST, creatinine, and INR. Thus, these
factors might be of reference value in the choice of clinical
treatment.
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Background: Hepatocellular carcinoma (HCC) is one of
the most common malignancies. Numerous studies have
suggested the potentially oncogenic roles of wild or mutant
hepatitis B virus X protein (HBx) in hepatocarcinogenesis.
To date, however, it remains unknown if HBx regulates
the expression of microRNAs (miRNAs) which negatively
regulate gene expression, playing essential roles in cell
differentiation and carcinogenesis.
Methods: MiRNA microarrays were employed to compare
the expression of cellular miRNAs in the LO2 cell line
that have been successfully established transfecting with
recombinant plasmid pcDNA3.0/HBx-d382, pcDNA/HBx and
plasmid pcDNA3.0 previously. Real-time Quantitative PCR
was used to conﬁrm the chip results. MiR-338 3p was
functionally characterized in LO2 cells with transiently
altered miR-338 3p expression. The direct target of miR-
338 3p was validated using 3′UTR-reporter assay.
Results: Compared with the LO2/pcDNA3.0 cell, a total
of 1 miRNAs exhibited higher expression and 5 miRNAs
demonstrated lower expression in the LO2/HBx-d382 cell,
while 4 up-regulated and 11 down-regulated miRNAs were
observed in LO2/HBx cell. MiR-338 3p, which both down-
